Eton Pharmaceuticals is an American specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products including injectables, oral liquids, and ophthalmics. Eton Pharmaceuticals was founded in 2017 and is based in Deer Park, Illinois.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Eton Pharmaceuticals news
13.05.2022
Eton Pharmaceuticals' GAAP loss for 3 months of 2022 was $5.33 million, compared to a profit of $5.116 million in the previous year. Revenue decreased 5.47 times to $2.176 million from $11.897 million a year earlier.
Source: 
ir.etonpharma.com
ir.etonpharma.com
11.04.2022
Eton Pharmaceuticals has received FDA approval for Exela Pharma Sciences' generic cysteine hydrochloride Elcys. The drug is intended for use as a supplement to amino acid solutions to meet the nutritional needs of newborns.
Source: ir.etonpharma.com
ir.etonpharma.com
17.03.2022
Eton Pharmaceuticals' GAAP loss for 2021 was $1.955 million, down 14 times from $27.97 million the previous year. Revenue increased multiple times to $21.832 million from $0.039 million a year earlier.
Source: ir.etonpharma.com
ir.etonpharma.com
16.11.2021
Eton Pharmaceuticals' GAAP loss for 9M 2021 was $2.994 million, down 6.8 times from $20.283 million in the previous year. Revenue was $15.739 million. The company did not generate revenue a year earlier.
Source: ir.etonpharma.com
ir.etonpharma.com
General information
| Company name | Eton Pharmaceuticals |
|---|---|
| Tags | #pharmacy |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 21925 West Field Parkway Suite 235 Deer Park, IL 60010 United States |
| Mailing address | 21925 West Field Parkway Suite 235 Deer Park, IL 60010 United States |
| Website | ir.etonpharma.com |
| Information disclosure | www.sec.gov |
English (US) 